Variable | HR (95% CI) | P value |
---|---|---|
Platinum resistance | 5.13 (1.28-20.57) | 0.021 |
CD133 expression in primary ovarian cancer | 2.82 (0.66-12.17) | 0.163 |
Multiple CNS metastases | 1.11 (0.20-6.12) | 0.921 |
Multimodal therapy including SRS (SRS +/− neurosurgery +/− chemotherapy) for CNS metastases | 0.12 (0.03-0.55) | 0.007 |
CD133 cluster formation in CNS metastases | 12.08 (1.55-94.16) | 0.017 |